Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Eva, Montané"'
Autor:
Gustavo-Jorge Molina-Molina, Diana Rocío Garnica Velandia, Blanca Andrés-López, Carolina Perales, Laura Marin-Asensio, Yanina Jurgens, Olga Esteso, Carolina Escobar, Xavier Vidal, Lourdes Vendrell, Laura Gómez-Ganda, Dolores Rodríguez, Eva Montané, Victoria Cardona, Antònia Agustí
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Background: Hypersensitivity to beta-lactam (BL) antibiotics is one of the most frequent reported drug allergies. In our population, it is common to find labels of BL allergy in electronic medical records (EMRs) that have not been assessed. The objec
Externí odkaz:
https://doaj.org/article/67f39e095ae44f16979c022612bfa007
Autor:
Eva Montané, Javier Santesmases
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Objectives: To describe the characteristics of safety alerts issued by the Spanish Medicines Agency (AEMPS) and the Spanish Pharmacovigilance System over a 7-year period and the regulatory actions they generated.Methods: A retrospective analysis was
Externí odkaz:
https://doaj.org/article/56791b6ec6844bf8b6e33a822fba5f30
Autor:
Eva Montané, Ana Maria Barriocanal, Ana Lucía Arellano, Angelica Valderrama, Yolanda Sanz, Nuria Perez-Alvarez, Paula Cardona, Cristina Vilaplana, Pere-Joan Cardona
Publikováno v:
PLoS ONE, Vol 12, Iss 2, p e0171294 (2017)
BACKGROUND:Nyaditum resae® (NR) is a galenic preparation of heat-killed Mycobacterium manresensis, a new species of the fortuitum complex, that is found in drinkable water, and that has demonstrated to protect against the development of active TB in
Externí odkaz:
https://doaj.org/article/3c74d87573364b8f8678a875936e1be7
Autor:
Xavier Castells, Eva Montané
Publikováno v:
British Journal of Clinical Pharmacology. 87:3659-3671
Objectives To perform a systematic review of observational studies on the epidemiology of drug-related death (DRD) in patients requiring hospitalisation or while hospitalised (hospital-acquired DRD). Methods We conducted a systematic review of observ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65f4c63b6d478caef959b05f3365d5f3
https://doi.org/10.1111/bcp.14799
https://doi.org/10.1111/bcp.14799
Autor:
Patricia Beroiz, Eva Montané, Mónica Mengual Ballester, Mónica Rodríguez, Juan J. López-Núñez, Guillermo Mena
Publikováno v:
Medicina Clinica
Medicina Clínica
Medicina Clínica
Resumen Objetivo Caracterizar los episodios adversos relacionados con la asistencia sanitaria en pacientes infectados por SARS-CoV-2 fallecidos en un hospital de tercer nivel. Metodos Estudio observacional retrospectivo en el que se incluyeron los pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3327b6ba6460049038f9f61c15bd0b1
https://doi.org/10.1016/j.medcli.2020.11.002
https://doi.org/10.1016/j.medcli.2020.11.002
Autor:
Pilar Teixidor, Miguel Ángel Arráez, Glòria Villalba, Roser Garcia, Manel Tardáguila, Juan José González, Jordi Rimbau, Xavier Vidal, Eva Montané
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0149244 (2016)
BACKGROUND:During the last decade, the use of 5-aminolevulinic acid (5-ALA) has been steadily increasing in neurosurgery. The study's main objectives were to prospectively evaluate the effectiveness and safety of 5-ALA when used in clinical practice
Externí odkaz:
https://doaj.org/article/adab89ca035048b9aa83fb71866cb6a4
Autor:
Eva Montané, Javier Santesmases
Publikováno v:
Medicina Clínica (English Edition). 154:178-184
An adverse drug reaction (ADR) is defined as a response to a medicinal product which is noxious and unintended. ADRs are an important cause of morbidity and mortality and increase health costs. The pharmacovigilance systems allow the identification a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c28a4c0653a2a0029f5a9ca036f78e06
https://doi.org/10.1016/j.medcle.2019.08.005
https://doi.org/10.1016/j.medcle.2019.08.005
Autor:
Eva Montané, Javier Santesmases
Publikováno v:
Medicina Clínica. 154:178-184
Resumen Se define como reaccion adversa a medicamentos (RAM) cualquier respuesta nociva y no intencionada a un medicamento. Las RAM constituyen una importante causa de morbimortalidad y de aumento de los costes sanitarios. Los sistemas de farmacovigi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a32e5210c135990e2098ebe4b891544
https://doi.org/10.1016/j.medcli.2019.08.007
https://doi.org/10.1016/j.medcli.2019.08.007
Publikováno v:
Educación Médica, Vol 20, Iss 5, Pp 295-303 (2019)
Recercat. Dipósit de la Recerca de Catalunya
instname
Recercat. Dipósit de la Recerca de Catalunya
instname
Introduction: Television medical dramas enjoy great popularity among the general public and university students. These dramas have been used to illustrate important aspects of medical training (doctor–patient relationships, professionalism, ethical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c01a11d38f42d88fa17774e750b7d1cd
http://www.sciencedirect.com/science/article/pii/S1575181319300907
http://www.sciencedirect.com/science/article/pii/S1575181319300907
Autor:
Guillermo Mena, Eva Montané, Mónica Rodríguez, Patricia Beroiz, Mónica Mengual Ballester, Juan J. López-Núñez
Publikováno v:
Medicina Clínica (English Edition)
Medicina Clinica (English Ed.)
Medicina Clinica (English Ed.)
Objective To characterize health care-related adverse events in patients with SARS-CoV-2 infection who died in a tertiary hospital. Methods This is a retrospective, observational study, that included patients who died at HUGTiP hospital between 16 Ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edc0c139ea8ce331317057ffb8b88676